The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Loh Evan since 2015.
This trader's CIK number is 1622680.
At the time of last reporting, Loh Evan was the CEO of Paratek Pharmaceuticals, Inc.. (stock ticker symbol PRTK).
Also see all insider trading activities at Paratek Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | EIGR | 0 | $0 | 2,000 | $20,280 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | PRTK | 0 | $0 | 48,967 | $107,727 | 0 | $0 |
| 2022 | PRTK | 0 | $0 | 153,074 | $345,239 | 0 | $0 |
| 2021 | PRTK | 0 | $0 | 121,007 | $550,019 | 0 | $0 |
| 2020 | PRTK | 0 | $0 | 75,523 | $476,088 | 39,479 | $169,759 |
| 2019 | PRTK | 0 | $0 | 38,597 | $139,591 | 0 | $0 |
| 2018 | PRTK | 0 | $0 | 48,710 | $474,110 | 0 | $0 |
| 2017 | PRTK | 0 | $0 | 7,457 | $149,526 | 39,478 | $169,755 |
| 2015 | PRTK | 6,000 | $98,595 | 0 | $0 | 0 | $0 |
1. Eiger Biopharmaceuticals, Inc. (EIGR)
2. Paratek Pharmaceuticals, Inc. (PRTK)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-03-15 | EIGR | Sale | 2,000 | 10.14 | 20,280 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-08-09 | PRTK | Sale | 48,967 | 2.20 | 107,727 |
| 2022-12-12 | PRTK | Sale | 37,831 | 1.98 | 74,905 |
| 2022-12-13 | PRTK | Sale | 61,919 | 1.96 | 121,361 |
| 2022-10-28 | PRTK | Sale | 8,805 | 3.47 | 30,553 |
| 2022-08-09 | PRTK | Sale | 44,519 | 2.66 | 118,420 |
| 2021-12-15 | PRTK | Sale | 49,259 | 4.27 | 210,335 |
| 2021-12-14 | PRTK | Sale | 23,834 | 4.37 | 104,154 |
| 2021-12-13 | PRTK | Sale | 13,983 | 4.42 | 61,804 |
| 2021-08-17 | PRTK | Sale | 33,931 | 5.12 | 173,726 |
| 2020-12-11 | PRTK | Sale | 18,585 | 6.95 | 129,165 |
| 2020-12-14 | PRTK | Sale | 26,415 | 6.71 | 177,244 |
| 2020-11-13 | PRTK | Sale | 20,928 | 5.93 | 124,103 |
| 2020-10-29 | PRTK | Option Ex | 39,479 | 4.30 | 169,759 |
| 2020-05-12 | PRTK | Sale | 9,595 | 4.75 | 45,576 |
| 2019-12-12 | PRTK | Sale | 14,514 | 3.10 | 44,993 |
| 2019-10-08 | PRTK | Sale | 7,818 | 3.82 | 29,864 |
| 2019-10-03 | PRTK | Sale | 16,265 | 3.98 | 64,734 |
| 2018-12-12 | PRTK | Sale | 5,525 | 6.76 | 37,349 |
| 2018-12-13 | PRTK | Sale | 6,000 | 6.27 | 37,620 |
| 2018-10-15 | PRTK | Sale | 5,200 | 8.96 | 46,592 |
| 2018-10-03 | PRTK | Sale | 8,861 | 9.82 | 87,015 |
| 2018-07-02 | PRTK | Sale | 12,000 | 9.97 | 119,640 |
| 2018-04-09 | PRTK | Sale | 8,084 | 12.70 | 102,666 |
| 2018-02-05 | PRTK | Sale | 3,040 | 14.22 | 43,228 |
| 2017-07-19 | PRTK | Option Ex | 39,478 | 4.30 | 169,755 |
| 2017-07-05 | PRTK | Sale | 4,351 | 23.58 | 102,592 |
| 2017-02-06 | PRTK | Sale | 3,106 | 15.11 | 46,934 |
| 2015-12-11 | PRTK | Buy | 900 | 16.67 | 15,003 |
| 2015-12-10 | PRTK | Buy | 1,400 | 17.00 | 23,800 |
| 2015-11-16 | PRTK | Buy | 3,700 | 16.16 | 59,792 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Loh Evan (CEO of Paratek Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.